Hydrochlorothiazide/Telmisartan

氢氯噻嗪/替米沙坦

Report date: 2026/05/21 20:00:22

Base Information

Drug NameHydrochlorothiazide/Telmisartan
Drug Alias Name替米沙坦/氢氯噻嗪telmisartan and hydrochlorothiazideTelmisartan - hydrochlorothiazide替米沙坦氢氯噻嗪替米沙坦+氢氯噻嗪 +[14] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2000/11/17
Country/TerritoryUnited StatesSwedenTaiwan +[20] 
CombinationsYes HydrochlorothiazideTelmisartan
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBayer AGBoehringer Ingelheim International Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DA07
Related LinksKEGG